about
Measuring biomarkers in wastewater as a new source of epidemiological information: Current state and future perspectives.Facilitating high resolution mass spectrometry data processing for screening of environmental water samples: An evaluation of two deconvolution tools.Comparison of pharmaceutical, illicit drug, alcohol, nicotine and caffeine levels in wastewater with sale, seizure and consumption data for 8 European cities.Suspect screening of large numbers of emerging contaminants in environmental waters using artificial neural networks for chromatographic retention time prediction and high resolution mass spectrometry data analysis.Liquid chromatography-tandem mass spectrometry determination of synthetic cathinones and phenethylamines in influent wastewater of eight European cities.Increased levels of the oxidative stress biomarker 8-iso-prostaglandin F2α in wastewater associated with tobacco useCritical review on the stability of illicit drugs in sewers and wastewater samples.LC-QTOF MS screening of more than 1,000 licit and illicit drugs and their metabolites in wastewater and surface waters from the area of Bogotá, Colombia.Estimation of caffeine intake from analysis of caffeine metabolites in wastewater.Wastewater-based epidemiology to assess pan-European pesticide exposure.Critical evaluation of a simple retention time predictor based on LogKow as a complementary tool in the identification of emerging contaminants in water.Enantiomeric profiling of chiral illicit drugs in a pan-European study.Prediction of Collision Cross-Section Values for Small Molecules: Application to Pesticide Residue Analysis.Qualitative and quantitative temporal analysis of licit and illicit drugs in wastewater in Australia using liquid chromatography coupled to mass spectrometry.Monitoring a large number of pesticides and transformation products in water samples from Spain and Italy.UHPLC-QTOF MS screening of pharmaceuticals and their metabolites in treated wastewater samples from Athens.Investigating the correlation between wastewater analysis and roadside drug testing in South Australia.LC-HRMS suspect screening to show spatial patterns of New Psychoactive Substances use in AustraliaComparison of phosphodiesterase type V inhibitors use in eight European cities through analysis of urban wastewaterScreening of pharmaceuticals and illicit drugs in wastewater and surface waters of Spain and Italy by high resolution mass spectrometry using UHPLC-QTOF MS and LC-LTQ-Orbitrap MS3-Fluorophenmetrazine, a fluorinated analogue of phenmetrazine: Studies on in vivo metabolism in rat and human, in vitro metabolism in human CYP isoenzymes and microbial biotransformation in Pseudomonas Putida and wastewater using GC and LC coupled tCharacteristics of known drug space. Natural products, their derivatives and synthetic drugsSimultaneous determination of 24 opioids, stimulants and new psychoactive substances in wastewaterSpatio-temporal assessment of illicit drug use at large scale: evidence from 7 years of international wastewater monitoringInvestigating the appearance of new psychoactive substances in South Australia using wastewater and forensic dataHarnessing the Power of the Census: Characterizing Wastewater Treatment Plant Catchment Populations for Wastewater-Based EpidemiologyAnabasine-based measurement of cigarette consumption using wastewater analysis
P50
Q30239884-6011D43A-79FE-4762-95DE-0F31AC56549DQ31111088-BF3D5315-955E-4962-9C35-5AEA480079A8Q31135493-E96984D3-0B51-4511-BBCD-018CA11C8AEEQ35771654-33BB8239-39D1-4548-9308-7D6DE1F286FAQ36183303-4A5DDF57-F077-4438-B261-F39833435984Q36224468-6C44AC4D-712A-4C4E-805B-10428D56D6EDQ38653119-8A2A7613-CEDA-4E66-A674-925D52FC69CCQ38994703-BD11D58E-6E6E-4E26-B29A-9CE91D6E201EQ40082390-EED15280-3B41-49DB-A031-445BB59A2218Q40181991-CF8DB51C-478C-4D20-8A4E-A37F097E5D34Q41060884-F4687C81-5A78-40CB-82CC-EC8960E035A8Q47272365-A38DEB04-3ABC-49F8-BBB7-C2BBC49F6065Q48029311-796CF67B-DD96-4914-B702-E742B67FED9FQ48578302-AAD67163-8417-48E1-9085-32B5AAA3A1E2Q50792339-F38EF991-9DEC-4536-BE1F-28B8073A4D10Q53128807-9318EFD5-F312-4982-99F6-BAE51FBF72B8Q53409476-1E2B0C01-CB43-4F77-9BAB-D56DF98E72A8Q57067683-C9974A01-50F1-4431-8466-FF018D622341Q57608024-4F18A33A-83EE-4DB1-A816-7923A6D14AC2Q57608052-A57B39EC-F8F5-40A9-A2F0-A5F90B3DA5AAQ58829042-1A526E57-68C7-4230-AC59-8396776A3289Q58829045-715395A6-1D3A-4A7A-B348-B98B3F675728Q64100850-DE4A9F4A-FCBB-4646-9FDE-4D5F8221170BQ90896795-451F70B4-F6B1-4104-9877-E4C7506E316FQ91058345-FB62E47D-36F2-4FFC-9E34-085D4C8A0E61Q92273453-D3B01208-DD09-4B9B-8DF6-DE6DA3604877Q96163544-D6833CD2-4310-4119-B541-5EB9041906C4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
R Bade
@ast
R Bade
@en
R Bade
@es
R Bade
@nl
R Bade
@sl
type
label
R Bade
@ast
R Bade
@en
R Bade
@es
R Bade
@nl
R Bade
@sl
prefLabel
R Bade
@ast
R Bade
@en
R Bade
@es
R Bade
@nl
R Bade
@sl
P106
P1153
37036806400
P31
P496
0000-0003-2724-9183